Merck Archives -

SMC approves medicines for breast cancer, skin cancer, schizophrenia

https://pharmaphorum.com/news/smc-approves-medicines-for-breast-cancer-skin-cancer-schizophrenia/

AZ and MSD’s Lynparza gets EU nod for hard-to-treat breast cancer

https://pharmaphorum.com/news/az-and-msds-lynparza-gets-eu-nod-for-hard-to-treat-breast-cancer/

Merck’s oral MS drug finally gets FDA okay

https://pharmaphorum.com/news/mercks-oral-ms-drug-finally-gets-fda-okay/

Exclusive speaker interviews with Merck and Sanofi – Injectable Drug Delivery 2019

https://pharmaphorum.com/partner-content/exclusive-speaker-interviews-with-merck-and-sanofi-injectable-drug-delivery-2019/

Merck and Pfizer stop third Bavencio ovarian cancer trial

https://pharmaphorum.com/news/merck-and-pfizer-stop-third-bavencio-ovarian-cancer-trial/

R&D round-up: Non-opioid painkiller space heats up

https://pharmaphorum.com/views-and-analysis/rd-roundup-non-opioid-painkiller-space-heats-up/

Merck adds to I-O stable with $300m Immune Design buy

https://pharmaphorum.com/news/merck-adds-to-i-o-stable-with-300m-immune-design-buy/

Keytruda combo set to become “standard of care” in kidney cancer

https://pharmaphorum.com/news/keytruda-combo-set-to-become-standard-of-care-kidney-cancer/

Merck/Pfizer up the pressure on BMS in first-line kidney cancer

https://pharmaphorum.com/news/merck-pfizer-up-the-pressure-on-bms-in-first-line-kidney-cancer/

Search